New research suggests there might not be a dependable benefit for low-risk patients taking daily aspirin as a low-cost protection against cancers of the lower bowel. However, the drug can increase the risk of dangerous bleeding by preventing clotting, according to a report published in the Cochrane Library Feb. 26. (Dreamstime/TNS)